07:00 , Oct 24, 2016 |  BC Week In Review  |  Financial News

Nektar completes follow-on

Nektar Therapeutics (NASDAQ:NKTR), San Francisco, Calif.  Business: Cancer, Neurology, Infectious  Date completed: 2016-10-18  Type: Follow-on  Raised: $175.5 million  Shares: 13 million  Price: $13.50  Shares after offering: 149.7 million  Underwriters: JPMorgan; Jefferies; Piper Jaffray; William Blair;...
07:00 , Oct 19, 2016 |  BC Extra  |  Financial News

Nektar raises $175.5M in follow-on

Nektar Therapeutics (NASDAQ:NKTR) raised $175.5 million through the sale of 13 million shares at $13.50 in a follow-on underwritten by JPMorgan, Piper Jaffray, William Blair, Brean Capital, BTIG, Janney Montgomery Scott, Ladenburg Thalmann and Roth...
07:00 , Jun 27, 2016 |  BC Week In Review  |  Financial News

Scynexis completes follow-on

Scynexis Inc. (NASDAQ:SCYX), Jersey City, NJ.   Business: Infectious, Ophthalmic   Date completed: 2016-06-21   Type: Follow-on   Raised: $22.5 million   Shares: 9.4 million   Price: $2.40   Shares after offering: 23.3 million  ...
07:00 , May 23, 2016 |  BioCentury  |  Strategy

Continental appetite

Having cut its teeth on the successful U.S. launch of Jakafi ruxolitinib, Incyte Corp. now has global aspirations for the rest of its pipeline. The acquisition of Ariad Pharmaceuticals Inc .'s European commercial business is...
07:00 , May 9, 2016 |  BC Week In Review  |  Financial News

Neuralstem completes follow-on

Neuralstem Inc. (NASDAQ:CUR), Rockville, Md.   Business: Neurology   Date completed: 2016-05-03   Type: Follow-on   Raised: $8 million   Shares: 20 million   Price: $0.40   Shares after offering: 112 million   Underwriters: Roth...
08:00 , Jan 11, 2016 |  BC Week In Review  |  Financial News

Akebia completes follow-on

Akebia Therapeutics Inc. (NASDAQ:AKBA), Cambridge, Mass.   Business: Hematology, Cardiovascular   Date completed: 2016-01-06   Type: Follow-on   Raised: $65.3 million   Shares: 7.3 million   Price: $9   Shares after offering: 37.9 million  ...
08:00 , Jan 4, 2016 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/31 cls ArQule Inc. (NASDAQ:ARQL) RBC Capital Markets Adnan Butt Upgrade Outperform (from sector performer) -3% $2.17 Butt also raised...
08:00 , Nov 23, 2015 |  BC Week In Review  |  Financial News

Axsome Therapeutics completes IPO

Axsome Therapeutics Inc. (NASDAQ:AXSM), New York, N.Y.   Business: Neurology   Date completed: 2015-11-19   Type: IPO   Raised: $51 million   Shares: 5.7 million   Price: $9   Shares after offering: 19.1 million  ...
01:56 , Nov 20, 2015 |  BC Extra  |  Financial News

Axsome dips after $51M IPO

Axsome Therapeutics Inc. (NASDAQ:AXSM) slipped $0.26 to $8.74 on Thursday after raising $51 million through the sale of 5.7 million shares at $9 in an IPO underwritten by Ladenburg Thalmann, Cantor Fitzgerald and Brean Capital....
08:00 , Nov 9, 2015 |  BC Week In Review  |  Financial News

Axsome Therapeutics amends IPO

Axsome Therapeutics Inc. , New York, N.Y.   Business: Neurology   Date announced: 2015-11-02   Type: IPO   To be raised: Up to $55.3 million   Shares: 4.3 million   Price: $11-$13   Underwriters: Ladenburg...